Infectious Diseases and Therapy

909 papers and 12.4k indexed citations i.

About

The 909 papers published in Infectious Diseases and Therapy in the last decades have received a total of 12.4k indexed citations. Papers published in Infectious Diseases and Therapy usually cover Epidemiology (469 papers), Infectious Diseases (441 papers) and Molecular Medicine (112 papers) specifically the topics of Pneumonia and Respiratory Infections (162 papers), Antibiotic Resistance in Bacteria (112 papers) and Respiratory viral infections research (109 papers). The most active scholars publishing in Infectious Diseases and Therapy are Michael J. Rybak, Susan L. Davis, Álex Soriano, Xavier Carbonell‐Estrany and J. Figueras Aloy.

In The Last Decade

Fields of papers published in Infectious Diseases and Therapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Infectious Diseases and Therapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Infectious Diseases and Therapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Infectious Diseases and Therapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Infectious Diseases and Therapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025